Search clinical trials for: calcium channel blocker

Total 15385 results

Eli Lilly and Company

Completed

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

Osteoporosis

United States
Merck Sharp & Dohme LLC

Completed

Antihypertensive Response to Losartan and Genetic Polymorphisms

Hypertension
University of Aarhus
Aarhus University Hospital; Regionshospitalet Silkeborg

Completed

Vitamin D and Type 2 Diabetes - a Cross Sectional Study

Type 2 Diabetes Mellitus | Hypovitaminosis D
Merck Sharp & Dohme LLC

Completed

A Study to Investigate the Antihypertensive Efficacy of MK0954

Hypertension
TransPharma Medical
Eli Lilly and Company

Completed

Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis

Osteoporosis

Israel, Czech Republic, Hungary
Merck Sharp & Dohme LLC

Completed

MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

Hypertension
University Hospital, Motol

Unknown

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Leukemia

Czech Republic
Institut Cancerologie de l'Ouest

Unknown

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Colorectal Cancer | Neurotoxicity | Chemotherapeutic Agent Toxicity

France
Elvir SAS
University Hospital, Clermont-Ferrand

Completed

Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D

Osteoporosis

France
Odense University Hospital

Unknown

Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

Atrial Fibrillation | Aortic Valve Stenosis | Left Ventricular Hypertrophy

Denmark
AstraZeneca

Completed

Effects of Crestor on Inflammation of Atherosclerotic Plaques

Atherosclerosis | Inflammatory Activity in Carotid Arteries

Sweden
AstraZeneca

Completed

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

Atherosclerosis | Inflammatory Activity in Coronary Arteries

Sweden
Shantha Biotechnics Limited

Completed

Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B

India
Aligarh Muslim University

Completed

The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

Metabolic Syndrome

India
St. Vincent's Medical Center
Medtronic - MITG

Unknown

The Effect of Rocuronium on the Response of Composite Variability Index (CVI) to Laryngoscopy

Laryngoscopy

United States
Brooke Army Medical Center

Unknown

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

United States
Istanbul University

Completed

Vascular Calcification, Inflammation and Coronary Flow Velocity in Hemodialysis Patients

Cardiovascular Diseases | Inflammation | Atherosclerosis | Renal Dialysis

Turkey
National Science Council, Taiwan

Completed

A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis

Cirrhosis | Variceal Bleeding
CONKO-Studiengruppe
Sanofi; Amgen; medac GmbH

Approved for marketing

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Pancreatic Cancer
Memorial Sloan Kettering Cancer Center

Completed

Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

Hodgkin's Disease

United States
Abbott

Completed

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
University of Magdeburg
Sanofi

Unknown

Irbesartan and Adhesion Molecules in AF (CREATIVE-AF)

Persistent Atrial Fibrillation

Germany
AstraZeneca

Completed

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Dyslipidaemia
Lahey Clinic

Completed

Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion

Dry Eye Syndrome

United States
Assistance Publique - Hôpitaux de Paris

Completed

Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening (BConvinced)

Heart Failure, Congestive

France
Mexican National Institute of Public Health

Unknown

Supplementation With Vitamin D Improves Leptin Resistance

Obesity | Overweight

Mexico
Govind Ballabh Pant Hospital

Completed

Primary Prophylaxis of Gastric Varix Bleed

Cirrhosis

India
University of Helsinki
AstraZeneca

Unknown

The Potential of Candesartan to Retard the Progression of Aortic Stenosis (ROCK-AS)

Aortic Valve Stenosis

Finland
Jazz Pharmaceuticals

Unknown

Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Oral Mucositis

United States
Catholic University of the Sacred Heart

Completed

Prostacyclin's Effect on Platelet Responsiveness

Acute Kidney Failure

Italy
Govind Ballabh Pant Hospital

Completed

Secondary Prophylaxis Gastric Variceal Bleed

Cirrhosis

India
Gruppo di Ricerca GISSI

Completed

GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

Atrial Fibrillation

Italy, Switzerland
Tohoku University

Completed

Vitamin D Supplementation Prevents Elderly Pneumonia

Bacterial Pneumonia

Japan
Uppsala University
Lund University; University of Aarhus

Completed

Open Versus Video-Assisted Minimal-Invasive Parathyroid Surgery

Primary Hyperparathyroidism

Denmark, Sweden
UPECLIN HC FM Botucatu Unesp

Completed

Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use HcT20 (EUWSFDAR)

Abnormalities, Radiation-Induced

Brazil
Universidad Autonoma de San Luis Potosí

Completed

Effect of Rosuvastatin in Intracerebral Hemorrhage

Stroke | Intracerebral Hemorrhage

Mexico
AstraZeneca

Withdrawn

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Primary Hypercholesterolaemia
AstraZeneca

Completed

Rosuvastatin ORBITAL Germany

Hypercholesterolemia
AstraZeneca

Completed

Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg (EXPLORER)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease
Pfizer

Completed

A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Osteoporosis

Argentina
Ramathibodi Hospital
AstraZeneca

Unknown

Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level

Systemic Lupus Erythematosus | High LDL Cholesterol Level

Thailand
AstraZeneca

Completed

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (HEROS)

Diabetes | Hypercholesterolemia | Coronary Heart Disease | Peripheral Vascular Disease | Cerebrovascular Accident
AstraZeneca

Completed

Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects

Hypercholesterolemia | Carotid Artery Stenosis
AstraZeneca

Completed

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks (POLARIS)

Hypercholesterolemia | Coronary Heart Disease
AstraZeneca

Completed

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) (IRIS)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

Hypercholesterolaemia
AstraZeneca

Completed

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

Hypercholesterolemia
AstraZeneca

Completed

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) (ARIES)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Metabolic Syndrome | Dyslipidemia

Australia
AstraZeneca

Completed

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

Coronary Artery Disease | Myocardial Ischaemia

3

Subscribe